Division of Environmental Health Radiation Protection Section Radioactive Materials Branch PUBLICATION 97-01 Official Listing of Radioactive Materials Approved for the Four Groups of Diagnostic Uses as Defined in.0321 Issuance Date: November 5, 2004 Revision No.: 4 Electronic Version (Added/amended entries are in bold italic typeface)
Publication 97-01(Revision 4) Page 2 of 5 GROUP I Diagnostic Studies Involving Uptake, Dilution and Excretion 1. Chromium 51 1. a. Sodium Chromate b. Labeled Human Serum Albumin 2. Cobalt 57, 58, 60 2. Labeled cyanocobalamin 3. Iodine 123 3. Sodium Iodide 4. Iodine 125 4. a. Sodium Iodide b. Iodinated human serum c. Oleic Acid d. Sodium iothalamate 5. Iodine 131 5. a. Sodium Iodide b. Iodinated Human Serum c. Triolein d. Sodium iodohippurate e. Sodium Rose Bengal 6. Iron 59 6. Ferrous citrate Per.0321(c)(3), for Groups I,
Publication 97-01(Revision 4) Page 3 of 5 GROUP II Diagnostic Studies Involving Imaging and Tumor Localization 1. Fluorine 18 1. a. Fluorine b. Fluorodeoxyglucose (FDG) 2. Chromium 51 2. Human serum albumin 3. Gallium 67 3. Gallium citrate 4. Gold 198 4. Colloidal (Aureotope) 5. Indium 111 5. a. Indium DTPA b. Indium oxyqunioline c. Pentetreotide d. Indium Satumomab pendetide 6. Iodine 123 6. a. Sodium iodide b. Iodohippurate sodium c. Iofetamine HCl 7. Iodine 125 7. a. Sodium iodide b. Fibrinogen 8. Iodine 131 8. a. Sodium iodide b. Iodinated human serum albumin c. Macroaggregated iodinated human serum albumin d. Colloidal (microaggregated) iodinated human serum albumin e. Sodium iodohippurate f. Iobenguanine sulfate (MIBG) g. Sodium Rose Bengal 9. Mercury 197, 203 9. Chlormerodrin 10. Selenium 75 10 Selenomethionine 11. Strontium 85 11. Nitrate 12. Technetium 99m 12. a. Sodium Pertechnetate b. Sulfur Colloid c. Macroaggregated human serum albumin (MAA) d. Fanolesomab (Neutrospec) 13. Thallium 201 13. Thallous chloride 14. Ytterbium 169 14. Penetate calcium trisodium (DTPA) 15. Rubidium 82 15. Rubidium Chloride (Cardiogen 82) Per.0321(c)(3), for Groups I,
Publication 97-01(Revision 4) Page 4 of 5 GROUP III Generators and Reagent Kits 1. Molybdenum 99/ Technetium 99m 1. Generator 2. Technetium 99m 2. a. Albumin Colloid b. Disofenin (Hepatolite) c. Etidronate sodium d. Gluceptate sodium e. Human Serum Albumin f. Human serum albumin (microspheres) g. Macroaggregated human serum albumin (MAA) h. Medronate Sodium i. Oxidronate sodium (HDP) j. Penetate sodium (DTPA) k. Pyro- and tirmetaphosphates l. Succimer (DMSA) m. Sulfur colloid n. Lidofenin (HIDA) o. Mebrofenin (Choletec) p. Exametazime (Ceretec) q. Teboroxime (CardioTec) r. Mertiatide (MAG3) s. Sestamibi (Cardiolite and Mirluma) t. Tetrofosmin (Myoview) u. Bicisate (Neurolite) v. Nofetumomab merpentan (Verluma) w. Arcitumomab (RBC-Scan) Labeled Red Blood Cells x. Apcitide (AcuTect) y. Depreotide (NeoTect) 3. Strontium 82/ 3. a. Generator Rubidium 82 b. Cardiogen 82 4. Indium 111 4. a. Capromab penedetide b. Satumomab pendetide (Oncoscint) c. Indium chloride (Indiclor) d. Pentetreotide (Ostreoscan) 5. Cobalt 57, 58 5. a. Cobalt chloride b. Cyanocobalamin (Dicopac) c. Rubatope Per.0321(c)(3), for Groups I,
Publication 97-01(Revision 4) Page 5 of 5 GROUP IV Therapeutic Uses Which Do Not Normally Require Hospitalization For The Purposes of Radiation Safety 1. Iodine 131 1. Sodium Iodide 1. Treatment of hyperthyroidism and cardiac dysfunction 2. Phosphorus 32 2. a. Sodium phosphate 2. a. Treatment of polycythemia vera, leukemia; palliative treatment of selected patients with multiple areas of skeletal metastases b. Indium oxyqunioline b. Intracavitary treatment of malignant effusions 3. Strontium 89 3. Strontium chloride (Metastron) 3. Relief of bone pain in patients with painful skeletal metastases 4. Samarium 153 4. Samarium lexidronam (Quadramet) 4. Relief of pain in patients with confirmed osteoblastic metastatic bone lesions 5. Gold 198 5. Colloidal (Aureotope) 5. Palliative management of ascites and pleural effusion associated with metastatic malignancies.